WELLS FARGO & COMPANY/MN

Position in HURA — TuHURA Biosciences, Inc./NV

CIK 72971 SAN FRANCISCO, CA

Position in HURA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,381

-$26,842 QoQ

Shares Held

1,873

-89.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#67

of 90 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. HURA ranks #338 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	749,528	$372,313,040
2	HALO	Halozyme Therapeutics, Inc.	1,390,428	$108,828,797
3	ALNY	Alnylam Pharmaceuticals, Inc.	310,047	$93,333,446
4	REGN	Regeneron Pharmaceuticals, Inc.	140,802	$87,795,677
5	EXEL	Exelixis, Inc.	717,840	$39,057,673
6	RVMD	Revolution Medicines, Inc.	178,780	$33,481,916
7	ARGX	Argenx SE	34,453	$31,964,458
8	INCY	Incyte Corp	255,064	$28,914,053

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,381	1,873	-89.3%	Shares	Defined	2026-08-14
2026-03-31	$31,223	17,444	-54.3%	Shares	Defined	2026-05-11
2025-12-31	$28,922	38,208	+109.0%	Shares	Defined	2026-02-13
2025-09-30	$45,326	18,277	+21.2%	Shares	Defined	2025-11-13
2025-06-30	$33,617	15,075	+737.5%	Shares	Defined	2025-08-14
2025-03-31	$5,814	1,800	0.0%	Shares	Defined	2025-05-13
2024-12-31	$7,362	1,800	—	Shares	Defined	2025-02-13
2024-09-30 KTRA	—	1,615	+6111.5%	Shares	Defined	2024-11-13
2024-03-31 KTRA	—	26	+100.0%	Shares	Defined	2024-05-10
2023-12-31 KTRA	—	13	+8.3%	Shares	Defined	2024-02-09
2023-09-30 KTRA	—	12	0.0%	Shares	Defined	2023-11-13
2023-06-30 KTRA	—	12	+9.1%	Shares	Defined	2023-08-15
2023-03-31 KTRA	—	11	0.0%	Shares	Defined	2023-05-12
2022-12-31 KTRA	—	11	—	Shares	Defined	2023-02-13
No filing history on record for this holder in this stock.